US Stock Market Move | Most of the Chinese pharmaceutical stocks rose, BEIGENE (ONC.US) by over 9%
Most Chinese pharmaceutical stocks are up, as of press time, BeiGene's shares surged more than 9%.
On Tuesday, most of the Chinese pharmaceutical stocks rose. As of press time, BeiGene (ONC.US) rose by over 9%, HutchMed (HCM.US) rose by over 4%; and Zai Lab (ZLAB.US) dipped slightly by 0.08%. In terms of news, BeiGene CEO John Oyler mentioned that, according to US Generally Accepted Accounting Principles, the company is expected to achieve a positive operating profit for the full year of 2025 (meaning that operating income will exceed the sum of operating costs, sales expenses, management expenses, and research and development expenses).
Related Articles
JIYI HOLDINGS (01495) announced its performance for the year 2024 with a net loss attributable to shareholders of 330 million yuan, a decrease of 33.81% year-on-year.
CMSC: Extreme differentiation between new and old economy in Hong Kong stocks. Information technology, pharmaceuticals, and internet sectors are thriving.
HK Bull/Bear Outstanding Qty Ratio(58:42) | September 18th
JIYI HOLDINGS (01495) announced its performance for the year 2024 with a net loss attributable to shareholders of 330 million yuan, a decrease of 33.81% year-on-year.
CMSC: Extreme differentiation between new and old economy in Hong Kong stocks. Information technology, pharmaceuticals, and internet sectors are thriving.
HK Bull/Bear Outstanding Qty Ratio(58:42) | September 18th
